Mizuho Securities Reiterates Neutral on Sabra Health Care REIT (SBRA) After Meeting with Management

October 10, 2016 7:51 AM EDT
Get Alerts SBRA Hot Sheet
Price: $22.37 +2.47%

Rating Summary:
    7 Buy, 10 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade SBRA Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Mizuho Securities reiterated a Neutral rating and $23.00 price target on Sabra Health Care REIT (NASDAQ: SBRA) after spending time with management. Mizuho said that the company comes off as much larger and influential in comparison to its relatively small size and believes that feeling comes from the operational mentality of senior management.

Analyst Richard Anderson commented, "We spent two days last week with SBRA senior management which provided insight into the company’s portfolio and strategy, as well as the post-acute and senior housing sectors in general -- the former dealing with CMS pilot programs that could test some operators' ability to remain profitable. Despite the positive impression we took away from the meetings, and there were many including management operating acumen, apparent progress on the GEN asset sales and a strong balance sheet, we remain Neutral on SBRA given the various elements of uncertainty related to execution and headline risk."

For an analyst ratings summary and ratings history on Sabra Healthcare REIT Inc. click here. For more ratings news on Sabra Healthcare REIT Inc. click here.

Shares of Sabra Healthcare REIT Inc. closed at $23.07 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments

Add Your Comment